CELLULAR NANOMED INC — Federal Contracts, Awards & Government Contractor Profile

About CELLULAR NANOMED INC

Cellular Nanomed Inc. develops magnetoelectric nanoparticle (MENP) technology for cancer treatment, offering a drug-free, minimally invasive theranostic approach that has shown significant survival gains in preclinical studies, particularly for pancreatic ductal adenocarcinoma (PDAC).

Development of magnetoelectric nanoparticles (MENPs) for cancer treatmentTheranostic treatment combining diagnosis and therapy using MENPsNon-invasive cancer cell targeting via magnetic field activationResearch and development in brain-computer interface and neuromodulationIntracellular drug delivery using nanotechnology

Is this your company?

Claim CELLULAR NANOMED INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim CELLULAR NANOMED INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.